Pubmed |
Diagnostic Accuracy of Microscopic Observation Drug Susceptibility (MODS) Assay for Pediatric Tuberculosis in Hanoi, Vietnam / I3434 Tran ST, Renschler JP, Le HT, Dang HT, Dao TM, Pham AN, et al. Diagnostic accuracy of microscopic observation drug susceptibility (MODS) assay for pediatric tuberculosis in hanoi, vietnam. PLoS ONE. 2013 Set; 8 (9): e72100.
|
2013 |
English |
Tran et al.3434 Tran ST, Renschler JP, Le HT, Dang HT, Dao TM, Pham AN, et al. Diagnostic accuracy of microscopic observation drug susceptibility (MODS) assay for pediatric tuberculosis in hanoi, vietnam. PLoS ONE. 2013 Set; 8 (9): e72100.
|
Due to its accessibility and low cost, MODS culture should be used as a routine test for symptomatic children with tuberculosis in low-resource settings. |
Pubmed |
The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study / J2222 Golla V, Snow K, Mandalakas AM, Schaaf HS, Du Preez K, Hesseling AC, et al. The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study. BMC Infect Dis. 2017 Ago; 17 (1): 593.
|
2017 |
English |
Golla et al.2222 Golla V, Snow K, Mandalakas AM, Schaaf HS, Du Preez K, Hesseling AC, et al. The impact of drug resistance on the risk of tuberculosis infection and disease in child household contacts: a cross sectional study. BMC Infect Dis. 2017 Ago; 17 (1): 593.
|
The study suggests that household contacts of children with multidrug-resistant tuberculosis are more likely to develop tuberculosis than people exposed to drugs. |
Pubmed |
Clinical and Drug Resistance Characteristics of New Pediatric Tuberculosis Cases in Northern China / K 2121 Wang T, Dong F, Li QJ, Yin QQ, Song WQ, Mokrousov I, et al. Clinical and drug resistance characteristics of new pediatric tuberculosis cases in northern china. Microb Drug Resist. 2018 Nov; 24 (9): 1397-403.
|
2017 |
English |
Wang et al.2121 Wang T, Dong F, Li QJ, Yin QQ, Song WQ, Mokrousov I, et al. Clinical and drug resistance characteristics of new pediatric tuberculosis cases in northern china. Microb Drug Resist. 2018 Nov; 24 (9): 1397-403.
|
The incidence of children with multidrug-resistant tuberculosis was as high as that found in adults. It is necessary to test for drug sensitivity in order to manage cases effectively |
Pubmed |
The Rate of Drug-Resistant Tuberculosis in Korean Children and Adolescents Since 2007 / L 2020 Kim HJ, Yoon HH, Eun BW, Ahn Y, Ryoo S, Kim HJ. The rate of drug-resistant tuberculosis in korean children and adolescents since 2007. J Korean Med Sci. 2017 Jun; 32 (6): 954-60.
|
2017 |
English |
Kim et al.2020 Kim HJ, Yoon HH, Eun BW, Ahn Y, Ryoo S, Kim HJ. The rate of drug-resistant tuberculosis in korean children and adolescents since 2007. J Korean Med Sci. 2017 Jun; 32 (6): 954-60.
|
There was an increase in the number of cases of drug resistance during the period proposed in the study.. |
Pubmed |
Prevalence of drug resistant Mycobacterium tuberculosis among children in China / M 1919 Jiao WW, Liu ZG, Han R, Zhao XQ, Dong F, Dong HY, et al. Prevalence of drug resistant Mycobacterium tuberculosis among children in China. Tuberculosis. 2015 Mai; 95 (3): 315-20.
|
2015 |
English |
Jiao et al.1919 Jiao WW, Liu ZG, Han R, Zhao XQ, Dong F, Dong HY, et al. Prevalence of drug resistant Mycobacterium tuberculosis among children in China. Tuberculosis. 2015 Mai; 95 (3): 315-20.
|
MDR-TB is due to primary transmission and inadequate treatment. Efforts to control the disease should focus on testing for resistance and reducing transmission. |
Pubmed |
Epidemiology and Clinical Characteristics of Pediatric Drug-Resistant Tuberculosis in Chongqing, China / N 4747 Guo Q, Pan Y, Yang Z, Liu R, Xing L, Peng Z, et al. Epidemiology and clinical characteristics of pediatric drug-resistant tuberculosis in chongqing, china. Plos One. 2016 Mar; 11 (3): e0151303.
|
2016 |
English |
Guo et al.4747 Guo Q, Pan Y, Yang Z, Liu R, Xing L, Peng Z, et al. Epidemiology and clinical characteristics of pediatric drug-resistant tuberculosis in chongqing, china. Plos One. 2016 Mar; 11 (3): e0151303.
|
The study generates reflections on the pathogenesis of MDR-TB and reiterates the need for further research on the subject in view of its relevance to the global control of the disease |
Pubmed |
Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children / O 1717 Kay AW, González Fernández L, Takwoingi Y, Eisenhut M, Vu RD, Steingart KR, et al. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev. 2020 Aug; 8 (8): CD013359.
|
2020 |
English |
Kay et al.1717 Kay AW, González Fernández L, Takwoingi Y, Eisenhut M, Vu RD, Steingart KR, et al. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev. 2020 Aug; 8 (8): CD013359.
|
A reduced number of studies and samples limite the safety of the study. Treatment needs to be based on the clinical information provided by the patients. |
Pubmed |
Safety of Longer Linezolid Regimen in Children with Drug Resistance Tuberculosis and Extensive Tuberculosis in Southwest China / P 3030 Zhang Z, Cheng Z, Liu Q, Shang T, Jiang L, Fu Z, et al. Safety of longer linezolid regimen in children with drug-resistant tuberculosis and extensive tuberculosis in Southwest China. J Glob Antimicrob Resist. 2020 Jun; 21: 375-9.
|
2019 |
English |
Zhang et al.3030 Zhang Z, Cheng Z, Liu Q, Shang T, Jiang L, Fu Z, et al. Safety of longer linezolid regimen in children with drug-resistant tuberculosis and extensive tuberculosis in Southwest China. J Glob Antimicrob Resist. 2020 Jun; 21: 375-9.
|
A large number of adverse events have been found in prolonged treatment of children taking Linezolid. It is necessary to monitor the laboratory tests of children undergoing this therapy throughout the treatment process. |
Pubmed |
Recommendations for Treating Children With Drug Resistant Tuberculosis/ Q 1515 Galli L, Lancella L, Garazzino S, Tadolini M, Matteelli A, Migliori GB, et al. Recommendations for treating children with drug-resistant tuberculosis. Pharmacol Res. 2016 Mar; 105: 176-82.
|
2016 |
English |
Galli et al.1515 Galli L, Lancella L, Garazzino S, Tadolini M, Matteelli A, Migliori GB, et al. Recommendations for treating children with drug-resistant tuberculosis. Pharmacol Res. 2016 Mar; 105: 176-82.
|
Children with MDR TB should be treated at a specialized center due to the possible adverse events of the treatment, its complexity and the low availability of the baseline studies for the treatment. |
Pubmed |
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta analysis / R99 Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, et al. Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis. PLOS Med. 2018 Jul; 15 (7): e1002591.
|
2018 |
English |
Harausz et al.99 Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, et al. Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis. PLOS Med. 2018 Jul; 15 (7): e1002591.
|
Children can achieve positive responses to MDR TB treatment and those with HIV should be using antiretroviral therapy during the TB treatment. |